BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38144572)

  • 21. High frequency of germline succinate dehydrogenase mutations in sporadic cervical paragangliomas in northern Spain: mitochondrial succinate dehydrogenase structure-function relationships and clinical-pathological correlations.
    Lima J; Feijão T; Ferreira da Silva A; Pereira-Castro I; Fernandez-Ballester G; Máximo V; Herrero A; Serrano L; Sobrinho-Simões M; Garcia-Rostan G
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4853-64. PubMed ID: 17848412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The
    Snezhkina A; Fedorova M; Kobelyatskaya A; Markova D; Lantsova M; Ikonnikova A; Emelyanova M; Kalinin D; Pudova E; Melnikova N; Dmitriev A; Krasnov G; Pavlov V; Kudryavtseva A
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel mutation in the SDHD gene responsible for familial paraganglioma. Medical and psychological implications.
    Prontera P; Ferrando B; Giuliani V; Falcinelli F; Mencarelli A; Rogaia D; Pasini B; Donti E
    Genet Couns; 2008; 19(4):413-8. PubMed ID: 19239085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of three new variants of SDHx genes in a cohort of Portuguese patients with extra-adrenal paragangliomas.
    Domingues R; Montalvão P; Magalhães M; Santos R; Duarte L; Bugalho MJ
    J Endocrinol Invest; 2012 Dec; 35(11):975-80. PubMed ID: 22293219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a signaling axis HIF-1α/microRNA-210/ISCU independent of SDH mutation that defines a subgroup of head and neck paragangliomas.
    Merlo A; de Quiros SB; Secades P; Zambrano I; Balbín M; Astudillo A; Scola B; Arístegui M; Suarez C; Chiara MD
    J Clin Endocrinol Metab; 2012 Nov; 97(11):E2194-200. PubMed ID: 22977270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of screening kindreds for SDHD p.Cys11X as a common mutation associated with paraganglioma syndrome type 1.
    Peczkowska M; Erlic Z; Hoffmann MM; Furmanek M; Cwikla J; Kubaszek A; Prejbisz A; Szutkowski Z; Kawecki A; Chojnowski K; Lewczuk A; Litwin M; Szyfter W; Walter MA; Sullivan M; Eng C; Januszewicz A; Neumann HP
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4818-25. PubMed ID: 18826997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance and peculiarities of succinate dehydrogenase B and hypoxia inducible factor 1α expression in parasympathetic versus sympathetic paragangliomas.
    Bernardo-Castiñeira C; Sáenz-de-Santa-María I; Valdés N; Astudillo A; Balbín M; Pitiot AS; Jiménez-Fonseca P; Scola B; Tena I; Molina-Garrido MJ; Sevilla MA; Beristein E; Forga L; Villabona C; Oriola J; Halperin I; Suarez C; Chiara MD
    Head Neck; 2019 Jan; 41(1):79-91. PubMed ID: 30549360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD.
    Ricketts CJ; Forman JR; Rattenberry E; Bradshaw N; Lalloo F; Izatt L; Cole TR; Armstrong R; Kumar VK; Morrison PJ; Atkinson AB; Douglas F; Ball SG; Cook J; Srirangalingam U; Killick P; Kirby G; Aylwin S; Woodward ER; Evans DG; Hodgson SV; Murday V; Chew SL; Connell JM; Blundell TL; Macdonald F; Maher ER
    Hum Mutat; 2010 Jan; 31(1):41-51. PubMed ID: 19802898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Case report of a man with multiple paragangliomas and pathogenic germline variants in both NF1 and SDHD.
    Chatzikyriakou P; Touska P; Moonim MT; Obholzer R; Afridi S; Sandison A; Oakey RJ; Izatt L
    Cancer Genet; 2021 Aug; 256-257():110-114. PubMed ID: 34107390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas.
    Burnichon N; Rohmer V; Amar L; Herman P; Leboulleux S; Darrouzet V; Niccoli P; Gaillard D; Chabrier G; Chabolle F; Coupier I; Thieblot P; Lecomte P; Bertherat J; Wion-Barbot N; Murat A; Venisse A; Plouin PF; Jeunemaitre X; Gimenez-Roqueplo AP;
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2817-27. PubMed ID: 19454582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malignant phenotype and two SDHD mutations in a family with paraganglioma syndrome type 1.
    Leidenz FB; Bastos-Rodrigues L; Oliveira M; Mamede M; Sarquis M; Friedman E; de Marco L
    Genet Res (Camb); 2015 Mar; 97():e3. PubMed ID: 25819804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High prevalence of SDHB mutations in head and neck paraganglioma in Belgium.
    Persu A; Hamoir M; Grégoire V; Garin P; Duvivier E; Reychler H; Chantrain G; Mortier G; Mourad M; Maiter D; Vikkula M
    J Hypertens; 2008 Jul; 26(7):1395-401. PubMed ID: 18551016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD gene.
    Taschner PE; Jansen JC; Baysal BE; Bosch A; Rosenberg EH; Bröcker-Vriends AH; van Der Mey AG; van Ommen GJ; Cornelisse CJ; Devilee P
    Genes Chromosomes Cancer; 2001 Jul; 31(3):274-81. PubMed ID: 11391798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 18F-FDG PET/CT as a predictor of hereditary head and neck paragangliomas.
    Blanchet EM; Gabriel S; Martucci V; Fakhry N; Chen CC; Deveze A; Millo C; Barlier A; Pertuit M; Loundou A; Pacak K; Taïeb D
    Eur J Clin Invest; 2014; 44(3):325-332. PubMed ID: 24422786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Somatic Mutation Profiling in Head and Neck Paragangliomas.
    Savvateeva M; Kudryavtseva A; Lukyanova E; Kobelyatskaya A; Pavlov V; Fedorova M; Pudova E; Guvatova Z; Kalinin D; Golovyuk A; Bulavkina E; Katunina I; Krasnov G; Snezhkina A
    J Clin Endocrinol Metab; 2022 Jun; 107(7):1833-1842. PubMed ID: 35460558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel succinate dehydrogenase subunit B germline variant associated with head and neck paraganglioma in a Dutch kindred: A family-based study.
    de Vos B; Rijken JA; Adank MA; Hoksbergen AWJ; Bayley JP; Leemans CR; Hensen EF
    Clin Otolaryngol; 2018 Jun; 43(3):841-845. PubMed ID: 29292578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Head/neck paragangliomas: focus on tumor location, mutational status and plasma methoxytyramine.
    Richter S; Qiu B; Ghering M; Kunath C; Constantinescu G; Luths C; Pamporaki C; Bechmann N; Meuter L; Kwapiszewska A; Deutschbein T; Nölting S; Peitzsch M; Robledo M; Prejbisz A; Pacak K; Gudziol V; Timmers HJLM; Eisenhofer G
    Endocr Relat Cancer; 2022 Mar; 29(4):213-224. PubMed ID: 35171114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Paragangliomas and paraganglioma syndromes].
    Boedeker CC
    Laryngorhinootologie; 2011 Mar; 90 Suppl 1():S56-82. PubMed ID: 21523634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma.
    Bayley JP; Kunst HP; Cascon A; Sampietro ML; Gaal J; Korpershoek E; Hinojar-Gutierrez A; Timmers HJ; Hoefsloot LH; Hermsen MA; Suárez C; Hussain AK; Vriends AH; Hes FJ; Jansen JC; Tops CM; Corssmit EP; de Knijff P; Lenders JW; Cremers CW; Devilee P; Dinjens WN; de Krijger RR; Robledo M
    Lancet Oncol; 2010 Apr; 11(4):366-72. PubMed ID: 20071235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SDHx gene detection and clinical Phenotypic analysis of multiple paraganglioma in the head and neck.
    Ding Y; Feng Y; Wells M; Huang Z; Chen X
    Laryngoscope; 2019 Feb; 129(2):E67-E71. PubMed ID: 30484866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.